← Back to all trials
Terminated
NCT05201014
Cancer Survivor Cardiomyopathy Detection
Conditions: Cardiovascular Diseases, Cancer
Sex: All
Ages: 18 Years – 99 Years
Healthy volunteers: No
Enrollment: 112
Sponsor: Mayo Clinic
Location: Mayo Clinic in Rochester Rochester Minnesota
Summary
The purpose of this study is to improve the cardiovascular care of adult cancer survivors. The goal is to obtain the data necessary to plan and develop a nation-wide network of a screening program that can help provide cost-effective and long-term monitoring.
Eligibility Criteria
Inclusion Criteria:
* ≥18 years of age prior to enrollment and anthracycline start date
* Diagnosis of breast cancer, lymphoma, or sarcoma with either planned or at 1 year after completion of anthracycline therapy, including patients from 6-12 months and greater than 1 year post-anthracycline exposure.
* Patients with a history of persistent atrial fibrillation (afib) that are not in afib remission. Include if the most recent ECG does not show afib. Atrial flutter treated the same
Exclusion Criteria:
* LVEF \
Source: ClinicalTrials.gov (NCT05201014). StuddyBuddy aggregates publicly available trial information.